Literature DB >> 17022693

Determination of complement factor H functional polymorphisms (V62I, Y402H, and E936D) using sequence-specific primer PCR and restriction fragment length polymorphisms.

Adrienn Bíró1, Zoltán Prohászka, George Füst, Bernadett Blaskó.   

Abstract

BACKGROUND: Complement factor H (CFH; HF) is an essential regulatory protein that plays a critical role in the homeostasis of the complement system in plasma. Several polymorphisms and mutations in the complement factor H gene (CFH; HF1) have been identified. These have revealed interesting associations with hemolytic-uremic syndrome and age-related macular degeneration. METHODS AND
RESULTS: The aim of this study was to develop a rapid and reliable assay for determining genotypic variants of the CFH gene. Sequence-specific primer PCR and restriction fragment length polymorphism techniques were chosen for the analysis of CFH polymorphisms. The assays detected the following published single nucleotide polymorphisms of CFH in our Caucasian population (n = 271): rs800292, 257G-->A (V62I); rs1061170, 1277T-->C (Y402H); and rs1065489, 2881G-->T (E936D). The allele frequencies (257G = 0.850, 1277T = 0.574, and 2881G = 0.839) that we obtained from a healthy Hungarian population were consistent with previously published results.
CONCLUSION: These analytical methods are simple, reliable, and rapid to perform, and are amenable to automation. Therefore, they could facilitate large-scale genotypic analyses of the CFH gene in various diseases, such as hemolytic-uremic syndrome, age-related macular degeneration, and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022693     DOI: 10.1007/BF03256205

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  26 in total

1.  An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32.

Authors:  S Rodríguez de Córdoba; M A Díaz-Guillén; D Heine-Suñer
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

2.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

3.  Genetic studies into inherited and sporadic hemolytic uremic syndrome.

Authors:  P Warwicker; T H Goodship; R L Donne; Y Pirson; A Nicholls; R M Ward; P Turnpenny; J A Goodship
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

4.  A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32.

Authors:  J H Weis; C C Morton; G A Bruns; J J Weis; L B Klickstein; W W Wong; D T Fearon
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 7.  Complement factor H and hemolytic uremic syndrome.

Authors:  P F Zipfel; C Skerka; J Caprioli; T Manuelian; H H Neumann; M Noris; G Remuzzi
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

8.  Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study.

Authors:  Robert Y L Zee; Kirsti A Diehl; Paul M Ridker
Journal:  Atherosclerosis       Date:  2005-10-17       Impact factor: 5.162

Review 9.  Complement factor H and related proteins: an expanding family of complement-regulatory proteins?

Authors:  P F Zipfel; C Skerka
Journal:  Immunol Today       Date:  1994-03

10.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  4 in total

1.  Elevated complement factor H levels in asthmatic sputa.

Authors:  Zsóka Weiszhár; András Bikov; Gabriella Gálffy; Lilla Tamási; Ildikó Ungvári; Csaba Szalai; György Losonczy; Ildikó Horváth
Journal:  J Clin Immunol       Date:  2012-10-17       Impact factor: 8.317

2.  Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.

Authors:  Yutaka Kato; Yasuharu Oguchi; Tomoko Omori; Hiroaki Shintake; Ryutaro Tomita; Akihito Kasai; Masashi Ogasawara; Yukinori Sugano; Kanako Itagaki; Akira Ojima; Takeshi Machida; Hideharu Sekine; Tetsuju Sekiryu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

3.  Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations.

Authors:  Henry G Hocking; Andrew P Herbert; David Kavanagh; Dinesh C Soares; Viviana P Ferreira; Michael K Pangburn; Dusan Uhrín; Paul N Barlow
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

4.  High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival.

Authors:  Blanka Mező; Roman Reindl-Schwaighofer; Farsad Eskandary; Andreas Heinzel; Markus Wahrmann; Konstantin Doberer; Andreas Heilos; Gregor Bond; Johannes Kläger; Nicolas Kozakowski; Helmuth Haslacher; Rainer Oberbauer; Ondřej Viklický; Petra Hrubá; Philip F Halloran; Krisztina Rusai; Zoltán Prohászka; Georg A Böhmig
Journal:  Transplant Direct       Date:  2020-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.